Scoggins Christopher J 4
4 · ABBOTT LABORATORIES · Filed Apr 3, 2019
Insider Transaction Report
Form 4
Scoggins Christopher J
EXECUTIVE VICE PRESIDENT
Transactions
- Award
Common shares without par value
2019-04-01+8,278→ 33,578 total - Award
Option (right to buy)
2019-04-01$79.98/sh+43,388$3,470,172→ 43,388 totalExercise: $79.98From: 2020-04-01Exp: 2029-03-31→ Common shares (43,388 underlying)
Footnotes (2)
- [F1]These shares represent performance-based restricted stock awards under the Abbott Laboratories 2017 Incentive Stock Program. The awards have a 3-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes.
- [F2]Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 14,462 on April 1, 2020, 14,463 on April 1, 2021, and 14,463 on April 1, 2022.